Innovations in Oncology and Drug Development

This chapter explores the impactful developments in oncology and various drug advancements, highlighting the transformative role of Wynrevere and Keytruda. The discussion includes a promising collaboration targeting small cell lung cancer, as well as the expansion of Gardasil's market potential. Additionally, it examines Regeneron's contributions to the industry, their challenges, and ongoing research efforts in addressing critical health needs.